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 We report a case of bronchiolitis obliterans organizing 
pneumonia (BOOP) caused by minocycline (MINO). A 59-
year-old man visited to our hospital because of flu-like 
symptoms. He had been treated with MINO for a few weeks 
for the skin eruption. The chest radiograph showed consoli-
dations in both lung fields. He was admitted to our hospi-
tal for further examination. An elevation of lymphocyte 
percentage was seen in his bronchoalveolar lavage and a 
diagnosis of BOOP was confirmed by video-assisted 
thoracoscopic lung biopsy. The symptoms, laboratory and 
radiological findings gradually improved without steroid 
therapy. Although the lymphocyte stimulation test (LST) of 
peripheral blood for MINO was negative, a positive oral 
provocation test confirmed the role of MINO in the induc-
tion of BOOP. 
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Introduction
its prognosis is usually benign'. 
 Minocycline (MINO) is a frequently used antibiotic 
for various infections such as inflammatory skin dis-
eases, purulent injuries, upper respiratory infections, 
and atypical pneumonia. Several adverse effects have 
been reported for MINO. These include vestibular dis-
turbances, candida infection, gastrointestinal distur-
bance, cutaneous symptoms (pigmentation, pruritus, 
photosensitive rash and urticaria), discoloration of the 
bone and dentition, benign intracranial hypertension, 
lupus syndrome, hypersensitivity reaction, autoimmune 
hepatitis, and pneumonitis Z - ". In one study, side effects 
were recorded in 13.6% of patients with acne vulgaris 
who were treated with 100-200 mg/day MINOZ'. 
 However, it is rare that MINO causes BOOP as a 
pulmonary involvement, although more than twenty 
cases of "MINO-induced pneumonitis" have been re-
ported in Japan as "drug-induced pneumonitis" or 
"eosinophilic pneumonia"'-"' . We encountered a rare 
case that was diagnosed as MINO-induced BOOP 
pathologically by video-assisted thoracoscopic lung bi-
opsy (VATS-LB). The diagnosis was confirmed by a 
positive oral provocation test.
 Bronchiolitis obliterans organizing pneumonia 
(BOOP) is mainly diagnosed pathologically as an inter-
stitial pneumonia characterized by the presence of 
granulation tissue and infiltration of inflammatory 
cells in the terminal and respiratory bronchioles. It is 
important to distinguish BOOP from other pulmonary 
diseases, especially idiopathic pulmonary fibrosis, be-
cause BOOP can respond well to steroid therapy and
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Case Report
 A 59-year-old man, a non-smoker, had a skin erup-
tion on the left hand for more than 10 years, which 
was noticed to grow slowly during this period. He vis-
ited the dermatology clinic at the local hospital on 
March 30th, 1998. Infection was highly suspected, 
which was treated with MINO at 200 mg/day orally 
from March 31st to April 19th. However, he became 
unwell on April 13th and complained of general mal-
aise on April 17th. Fever (38.7C) and dry cough ap-
peared on April 19th. He visited a clinic on April 24th 
because of exertional dyspnea with Hugh-Jones II°.
Chest X-ray showed abnormal shadows in the both 
lung fields and C-reactive protein (CRP) was 21.0 
mg/dl. The patient was transferred to our hospital for 
further examination of the abnormal shadows of the 
chest X-ray on April 30th. 
 On admission, he was 160 cm tall and weighed 53 
kg. Body temperature was 36.7°C, pulse rate 78 bpm, 
and blood pressure 134/80 mmHg. Examination of the 
cardiovascular system was normal and normal vesicu-
lar breath sound was heard over the lungs. There 
were no abnormal findings on examination of the ab-
domen, lower extremities or nervous system. A red 
eruption, measuring 5 X 5 cm, was noted on the 
dorsum of the left hand. Laboratory tests on admis-
sion showed the followings. Hemoglobin (Hb) 13.7 
g/dl, red blood cells (RBC) 475X104/,U1, white blood 
cells (WBC) 10,8001,u1, neutrophils 75%, lymphocytes 
12%, monocytes 10%, basophils 2%, and eosinophils 1%, 
platelet count 42.8X104/,U1, total protein 6.5 g/dl, al-
bumin 51.0%, a 1-globulin (gl) 5.1 %, a 2-gl 12.3%, 13 -gl 
11.2%, y -gl 20.4%, CRP 2.45 mg/dl, RA test was nega-
tive, and anti-nucleus antibody (ANA) test was nega-
tive. Anti-viral antibodies were negative except anti-
parainfluenza 3 virus (HI): X 512, and anti-RS virus 
(CF): X 8. Respiratory function tests showed restrictive 
ventilatory impairment; with vital capacity (VC) 1.95 
1, %VC 57.9%, forced expiratory volume in 1 second 
(FEV 1) 1.66 1, FEV 1 %; FEV 1 /forced vital capacity 
(FVC) 85.1%, residual volume (RV)/total lung capacity
Figure 1. Chest X-ray film on admission shows consolida-
tions in both left and right middle lung fields and the left 
upper lung field, mainly in the peripheral lung zones.
Figure 2. Chest CT scan on admission shows consolidations 
in both upper lobes and 156, mainly located in subpleural re-
gion.
(TLC) ratio 35.5%. Arterial blood gas analysis under 
room air revealed; PaO 2 78.8 torr, PaCO 2 42.4 torr, 
pH 7.451. A chest X-ray film showed consolidations in 
both right and left middle lung fields and the left 
upper lung field, mainly in peripheral lung zones (Fig 
1). Chest computed tomography (CT) scan revealed 
consolidations in bilateral upper lobes and left S6, 
mainly located in the subpleural region (Fig 2). 
Cytological examination of inducible sputum was 
negative. Bronchoscopic examination was performed 
on day 7 after admission. A fiberscope was wedged 
into left B 3 and bronchoalveolar lavage (BAL) was 
performed. Only 50 ml of sterile physiological saline 
was instilled once because of severe cough. Sixteen ml 
of BAL fluid (F) was retrieved, and analysis of BALF 
showed increased percentage of lymphocytes; total cell 
count of 2.9X105/Ml, macrophages 22.0%, neutrophils 
13.0%, lymphocytes 60.0%, eosinophils 4.0%, CD4/CD8 
ratio 0.62. Subsequently, VATS-LB was performed on 
day 19. Pathological findings of the specimens from 
left S 6 were as follows; there were no necrosis, hya-
line membrane, large space of fibrosis, or malignant 
cells. There were centrilobular granulation tissues. 
Accumulations of foamy cells, macrophages containing 
rich lipid, and infiltration of lymphocytes were seen in 
the small airways including respiratory bronchioles 
and alveolar ducts. Diffuse but mild thickening of al-
veolar wall was evident with proliferation of type II 
alveolar cells and mild fibrosis. Normal alveolar wall 
was noted in only about 5% of all alveoli (Fig 3A, B). 
Based on the above features, BOOP was established as 
the final diagnosis. Spontaneous recovery was noted 
on conservative treatment; dyspnea gradually disap-
peared, the inflammatory signs became negative, and 
the shadows on chest X-ray gradually improved as we
Figure 3. Histopathological findings of VATS-LB specimens 
from left S'. (A) Note the presence of centrilobular granula-
tion tissues (small arrowhead) and accumulation of macro-
phages (big arrowhead) (HE stain, X 16). (B) Granulations 
(small arrowhead) and foamy cells (big arrowhead) are seen 
in the small airways (HE stain, X80).
could not detect them. 
 The patient was seen at follow-up visit the derma-
tology clinic on June 9th in order to receive therapy 
for the skin eruption on the left hand. The lesion was 
diagnosed as the granuloma by common bacterial in-
fection, because the results of the skin cultures of the 
eruption in the local hospital were negative for atypi-
cal mycobacterium and sporotrichum. MINO was ad-
ministered at 200 mg twice daily for two days. Fever 
of 39.3°C, cough and yellow sputum appeared on June 
10th. Laboratory data were as follows; WBC 19,400/ 
,u l , neutrophils 83%, lymphocytes 1%, monocytes 10%, 
basophils 0%, eosinophils 6%, platelet count 17.3 X 10 4 / 
 1, CRP 19.74 mg/dl. The lymphocyte stimulation 
test (LST) of peripheral blood for MINO was negative. 
A chest X-ray film and chest CT scans showed recur-
rent shadows at the same regions seen on admission. 
Symptoms and abnormal shadows improved gradually 
without steroid therapy after discontinuation of MINO.
The above clinical presentation confirmed MINO-
induced BOOP, i.e., incidental positive oral provocation 
test.
Discussion
 The differential diagnosis in our patient included 
hypersensitivity pneumonitis, drug-induced pneumonitis, 
non-specific interstitial pneumonia (NSIP), or BOOP 
based on analysis of BALF, which showed increased 
percentage of lymphocytes and low CD4/CD8 ratio"'. 
Pathological findings of the specimens by VATS-LB 
were consistent with the findings of BOOR We had 
excepted BOOP induced by MINO out of differential 
diagnosis by misleading, because BOOP induced by 
MINO was too rare. There was only one case report of 
BOOP induced by MINO at that time. We introduced 
our patient to the dermatology clinic as a patient of 
idiopathic BOOP and we did not give the patient's his-
tory of MINO in details. The eruption was diagnosed 
as common bacterial infection and MINO was adminis-
tered again. As a result, the oral provocation test for 
MINO was positive and secondary BOOP as an ad-
verse reaction to MINO was diagnosed. 
 More than 20 cases of MINO-induced pneumonitis 
have been reported in the Japanese literature as drug-
induced pneumonitis or eosinophilic pneumonia'-"). 
The final diagnosis in these cases was based on exami-
nation of bronchoalveolar lavage (BAL), transbronchial 
lung biopsy (TBLB), and/or clinical course. 
Histopathologically, most cases showed infiltration of 
eosinophils8-10) . However, our case exhibited 
histopathological features consistent with BOOP by 
VATS-LB, which was induced by MINO, although 
most reported cases were negative to LST, similar to 
our case. 
 To our knowledge, only two cases of MINO-induced 
BOOP were reported" 13) Piperno et al.") reported a 
20-year-old female patient with MINO-induced BOOP, 
diagnosed by open lung biopsy. The patient had no 
symptoms and signs. Chest radiologic findings in-
cluded alveolar opacities, and lung function tests 
showed a mild restrictive ventilatory defect. The sec-
ond case of MINO-induced BOOP was reported by 
Kondo13'. The patient was 39-year-old woman who had 
been treated for acne with MINO as well as the first 
case. She had dry cough, and chest CT scans showed 
multiple ring-shaped opacities in both lungs. She was 
diagnoted by TBLB and her clinical course, although 
she was negative to LST, similar to most cases of 
MINO-induced pneumonitis. No provocation tests were 
performed in those two cases.
  Several groups have reported cases of drug-induced 
BOOP. including sulfasalazine14', penicillamine'S', bleomy-
cint6', nitrofurantoin"', phenytoin'$' and amiodarone19' 20'. 
The clinical features of these patients, chest X-ray 
findings, clinical course, and prognosis resemble those 
of other types of BOOP13-10' Therefore, physicians 
should be aware of BOOP as a possible adverse effect 
of MINO, although the underlying mechanisms in-
volved in the induction of BOOP by the above drugs 
remain to be identified. 
 In conclusion, a case history of treatment with 
MINO, fever, dyspnea, cough, inflammatory signs on 
laboratory data, restrictive respiratory dysfunction 
and alveolar opacities on radiological examination, 
may suggest MINO-induced BOOR However, patho-
logical diagnosis is necessary to rule out other types 
of drug-induced pulmonary diseases such as eosinophilic 
pneumonia, hypersensitivity pneumonitis, diffuse inter-
stitial pneumonia, or fibrosis.
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